The co-founder’s departure comes just months after activist investor Carl Icahn acquired an 8.5 percent stake in the mining company.
The French island has been sharply divided since a Christmas Eve attack injured two firefighters and one police officer.
Will Smith's "Concussion" brings to life the controversy over the safety of youth sports and the danger of long-term brain damage.
Many Republican governors accept federal funds to expand their health insurance programs.
Purchases of car dealerships rose by 40 percent in 2015, according to a report. Seasoned dealers see it as a good time to exit the market.
The ride-hailing industry wants to pull in a lot more cash from investors in the coming year.
The pharmaceutical and biotechnology industry will face heightened pressure in 2016 over pricing from insurers and politicians.
The Microsoft founder sold more than $1.5 billion in company stock this year, with Google founders Larry Page and Sergey Brin also cashing in.
Illnesses in three more states prompt a new investigation, with the restaurant chain's stock price hitting a 52-week low Monday before a slight recovery.
The agency says children who tan are at a far greater risk for developing melanoma later in life. Dermatologists hailed the proposal.
The controversial CEO, known for raising the price of a drug by 5,000 percent, has resigned, the pharmaceutical company said. Ron Tilles will step in as interim CEO.
The pharmaceutical CEO, arrested Thursday on fraud charges, earned public scorn over a massive drug price hike and crude comments about Taylor Swift.
By sourcing its food from small-scale local growers, the fast-casual restaurant chain may risk customers' health, critics say.
To win back customers and investors during its foodborne illness outbreak, the burrito chain is following an established playbook.
Federal regulators are cracking down on added sugars, and U.S. food companies are unsure how to react.
New state-by-state health rankings illuminate striking differences in the rates of diseases, behaviors and public health investments across the U.S.
A U.S. Senate hearing Wednesday will investigate drug price increases that have lately become more frequent and dramatic.
Private U.S. security providers located near the sites of mass shootings often see an influx of calls, but the effects could be short-lived.
Following Wednesday’s shooting in San Bernardino, California, corporate security experts are taking a second look at proactive steps to reduce workplace violence.
A 3-year-old project in Florida is showing early promise in improving patients’ care and satisfaction.